Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam dosing study in obese patients undergoing gastric volume reduction surgery
ChiCTR2200065602Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Shanghai Tenth People's Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in obesity (4 arms), sponsored by Department of Anesthesiology, Shanghai Tenth People's Hospital. Primary endpoint: OAA/S score. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2200065602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065602.